On September 14, 2023, the Federal Trade Commission (FTC) issued a statement condemning pharmaceutical manufacturers’ improper inclusion of patents in the Food and Drug Administration’s (FDA’s) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback